SCHEMBL19251019

SCHEMBL19251019

CSC(C)OCc1ccco1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
SLC1A3 P43003 1/20 0.45
SLC1A2 P43004 1/20 0.45
SLC1A1 P43005 1/20 0.45
GAA P10253 2/20 0.41
LMNA P02545 2/20 0.40
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.35
HPGD P15428 4/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 1/20 0.35
ACACB O00763 1/20 0.34
MAPK1 P28482 2/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HTT P42858 2/20 0.34
MAPT P10636 2/20 0.34
USP2 O75604 2/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6237784 0.81 ALDH1A1 (0.52) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL1845031 0.78 ALDH1A1 (0.53) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL28835773 0.76 ALDH1A1 (0.47) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL17320587 0.76 ALDH1A1 (0.47) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL4620314 0.75 ALDH1A1 (0.50) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL4620318 0.75 ALDH1A1 (0.50) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL23089952 0.74 SLC1A3 (0.48) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL12611216 0.72 SLC1A3 (0.61) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL11254941 0.72 ALDH1A1 (0.47) ALDH1A1SLC1A3SLC1A2SLC1A1GAA
SCHEMBL2266382 0.71 ALDH1A1 (0.69) ALDH1A1SLC1A3SLC1A2SLC1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9878987-B2 HSP70 modulators and methods for making and using the same MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2018-01-30 US disclosed
US-20170233352-A1 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME MEMORIAL SLOAN KETTERING CANCER CENTER 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233352-A1 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME HSPA2, HSP90AA1, HSP90AB1 ALDH1A1 458/4885SLC1A3 4312/4885SLC1A2 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.